New Drugs FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma 6 years ago
New Drugs Lynparza (olaparib) Approved by US FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer 6 years ago
New Drugs FDA Approves New Indication for Envarsus XR (tacrolimus extended-release tablets) 6 years ago